Since overexpression of HER-2 has been linked with activation of AKT/mTOR signals that are involved in tumor biology27, 37, the decreased AKT/mTOR phosphorylation with CoQ0 perhaps contributes to effective management of the ovarian cancer progression. The gene discussed is ERBB2; the disease is ovarian carcinoma.